Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura

Kidney International

Volumn 78, Issue 5, 2010, Pages 495-502

  Pillebout, Evangéline ^a   Alberti, Corinne ^b   Guillevin, Loic ^c   Ouslimani, Amel ^d   Thervet, Eric ^e  

^a SAINT LOUIS HOSPITAL   (France)

^b Section of Radiology   (France)

^c CHU Cochin ^*  (France)

^d HÔpital Saint Louis   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

adult; clinical trial; cyclophosphamide; Henoch Schonlein Purpura; nephritis; steroids

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISONE;

ACNE VULGARIS; ADD ON THERAPY; ADULT; AGED; ALOPECIA; ANAPHYLACTOID PURPURA; ARTICLE; BRONCHITIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG SAFETY; FEMALE; HEART INFARCTION; HEMORRHAGIC SHOCK; HERPES ZOSTER; HUMAN; HUMAN TISSUE; INFECTION; INSOMNIA; KIDNEY BIOPSY; KIDNEY FUNCTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NECROTIZING FASCIITIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; REMISSION; STEROID THERAPY; TUBERCULOSIS; URINARY TRACT INFECTION; VERTEBRA FRACTURE;

EID: 77955653597     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.150     Document Type: Article

References (20)

1. Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V et al. Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 1997; 40: 859-864.
2. Garcia-Porrua C, Calvino MC, Llorca J et al. Henoch-Schonlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 2002; 32: 149-156.
3. Saulsbury FT. Clinical update: Henoch-Schonlein purpura. Lancet 2007; 369: 976-978.
4. Kellerman PS. Henoch-Schonlein purpura in adults. Am J Kidney Dis 2006; 48: 1009-1016.
5. Chartapisak W, Opastirakul S, Hodson EM et al. Interventions for preventing and treating kidney disease in Henoch-Schonlein Purpura (HSP). Cochrane Database Syst Rev. 2009. CD005128.
6. Zaffanello M, Fanos V. Treatment-based literature of Henoch-Schonlein purpura nephritis in childhood. Pediatr Nephrol 2009; 24: 1901-1911.
7. Weiss PF, Feinstein JA, Luan X et al. Effects of corticosteroid on Henoch-Schonlein purpura: a systematic review. Pediatrics 2007; 120: 1079-1087.
8. Shenoy M, Bradbury MG, Lewis MA et al. Outcome of Henoch-Schonlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol 2007; 22: 1717-1722.
9. Donnithorne KJ, Atkinson TP, Hinze CH et al. Rituximab therapy for severe refractory chronic Henoch-Schonlein purpura. J Pediatr 2009; 155: 136-139.
10. Rostoker G. Schonlein-Henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs 2001; 15: 99-138.
11. Pillebout E, Thervet E, Hill G et al. Henoch-Schonlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002; 13: 1271-1278.
12. Shrestha S, Sumingan N, Tan J et al. Henoch Schonlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. QJM 2006; 99: 253-265.
13. Coppo R, Andrulli S, Amore A et al. Predictors of outcome in Henoch-Schonlein nephritis in children and adults. Am J Kidney Dis 2006; 47: 993-1003.
14. Rauta V, Tornroth T, Gronhagen-Riska C. Henoch-Schoenlein nephritis in adults\clinical features and outcomes in Finnish patients. Clin Nephrol 2002; 58: 1-8.
15. Diehl MP, Harrington T, Olenginski T. Elderly-onset Henoch-Schonlein purpura: a case series and review of the literature. J Am Geriatr Soc 2008; 56: 2157-2159.
16. Praga M, Gutierrez E, Gonzalez E et al. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol 2003; 14: 1578-1583.
17. Woo KT, Lau YK, Wong KS et al. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis. Kidney Int 2000; 58: 2485-2491.
18. Nakao N, Seno H, Kasuga H et al. Effects of combination treatment with losartan and trandolapril on office and ambulatory blood pressures in non-diabetic renal disease: a COOPERATE-ABP substudy. Am J Nephrol 2004; 24: 543-548.
19. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192.
20. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87: 671-678.